Liver transplantation for metabolic disorders

Area of Science:

• Hepatology and Metabolic Medicine
• Transplantation Surgery

Background:

• Liver transplantation for metabolic disorders is a growing area with expanding indications and patient numbers.
• It represents a significant portion of all liver transplants, particularly in pediatric cases (29%).
• Advancements in medical therapy are paralleling improvements in transplant outcomes, increasing consideration for this treatment.

Purpose of the Study:

• To highlight the expanding role of liver transplantation in managing metabolic disorders.
• To underscore the dual benefits of transplantation: improved patient outcomes and deeper metabolic insights.

Main Methods:

• Review of large-scale transplant series focusing on metabolic disorder indications.
• Analysis of patient demographics (adult vs. pediatric) and transplant prevalence.
• Assessment of the impact of improved medical therapies on transplantation candidacy.

Main Results:

• Liver transplantation accounts for approximately 7% of adult and 29% of pediatric transplants in major series.
• Improved medical treatments are leading to increased consideration for liver transplantation.
• Transplantation offers significant improvements in patient survival and quality of life.

Conclusions:

• Liver transplantation is a vital and expanding therapeutic option for patients with metabolic disorders.
• The procedure not only extends and enhances life but also provides crucial insights into metabolic disease pathophysiology.
• Continued advancements in transplant outcomes will likely further increase its application in metabolic conditions.